Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS Academic Article Article uri icon

Overview

MeSH Major

  • Lipoproteins, HDL

abstract

  • Lovastatin reduces the risk for the first acute major coronary event in men and women with average TC and LDL-C levels and below-average HDL-C levels. These findings support the inclusion of HDL-C in risk-factor assessment, confirm the benefit of LDL-C reduction to a target goal, and suggest the need for reassessment of the National Cholesterol Education Program guidelines regarding pharmacological intervention.

publication date

  • May 27, 1998

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1001/jama.279.20.1615

PubMed ID

  • 9613910

Additional Document Info

start page

  • 1615

end page

  • 22

volume

  • 279

number

  • 20